ListarReumatoloxía por tema "Nonradiographic axial spondyloarthritis"
Mostrando ítems 1-1 de 1
-
Etanercept withdrawal and retreatment in nonradiographic axial spondyloarthritis: results of RE-EMBARK, an open-label phase IV trial
(Journal of Rheumatology Publishing, 2023-04)[Abstract] Objective: RE-EMBARK investigated etanercept (ETN) withdrawal and retreatment in patients with nonradiographic axial spondyloarthritis (nr-axSpA) achieving inactive disease. Methods: Patients received ETN and ...